- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Detection of bladder tumor cells using motion features in urine ; volume:15 ; number:1 ; day:10 ; month:6 ; year:2024 ; pages:1-8 ; date:12.2024
Journal of analytical science and technology ; 15, Heft 1 (10.6.2024), 1-8, 12.2024
- Creator
-
Kim, Minsuk
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40543-024-00451-3
- URN
-
urn:nbn:de:101:1-2408162116035.394419091502
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kim, Minsuk
- SpringerLink (Online service)
Other Objects (12)
Bladder cancer detection in urine by novel methylation markers
Improved urine DNA methylation panel for early bladder cancer detection
Clinical evaluation of Bladder CARE, a new epigenetic test for bladder cancer detection in urine samples
A prospective comparison of UroVysion FISH and urine cytology in bladder cancer detection
Comparison and combination of mutation and methylation-based urine tests for bladder cancer detection
Putative markers for the detection of early-stage bladder cancer selected by urine metabolomics
Pedestrian detection with motion features via two-stream ConvNets
Exploring urine sediments as a non-invasive method for DNA methylation detection in bladder cancer
Bladder cancer detection in urine using DNA methylation markers: a technical and prospective preclinical validation
Adenoviral infectivity of exfoliated viable cells in urine: Implications for the detection of bladder cancer
Bladder cancer recurrence surveillance by urine metabolomics analysis
A urine-based DNA methylation assay to facilitate early detection and risk stratification of bladder cancer
Bladder cancer detection in urine by novel methylation markers
Improved urine DNA methylation panel for early bladder cancer detection
Clinical evaluation of Bladder CARE, a new epigenetic test for bladder cancer detection in urine samples
A prospective comparison of UroVysion FISH and urine cytology in bladder cancer detection
Comparison and combination of mutation and methylation-based urine tests for bladder cancer detection
Putative markers for the detection of early-stage bladder cancer selected by urine metabolomics
Pedestrian detection with motion features via two-stream ConvNets
Exploring urine sediments as a non-invasive method for DNA methylation detection in bladder cancer
Bladder cancer detection in urine using DNA methylation markers: a technical and prospective preclinical validation
Adenoviral infectivity of exfoliated viable cells in urine: Implications for the detection of bladder cancer
Bladder cancer recurrence surveillance by urine metabolomics analysis
A urine-based DNA methylation assay to facilitate early detection and risk stratification of bladder cancer
Bladder cancer detection in urine by novel methylation markers
Improved urine DNA methylation panel for early bladder cancer detection
Clinical evaluation of Bladder CARE, a new epigenetic test for bladder cancer detection in urine samples
A prospective comparison of UroVysion FISH and urine cytology in bladder cancer detection
Comparison and combination of mutation and methylation-based urine tests for bladder cancer detection
Putative markers for the detection of early-stage bladder cancer selected by urine metabolomics
Pedestrian detection with motion features via two-stream ConvNets
Exploring urine sediments as a non-invasive method for DNA methylation detection in bladder cancer
Bladder cancer detection in urine using DNA methylation markers: a technical and prospective preclinical validation
Adenoviral infectivity of exfoliated viable cells in urine: Implications for the detection of bladder cancer
Bladder cancer recurrence surveillance by urine metabolomics analysis